A detailed history of Decheng Capital Management Iii (Cayman), LLC transactions in Terns Pharmaceuticals, Inc. stock. As of the latest transaction made, Decheng Capital Management Iii (Cayman), LLC holds 714,285 shares of TERN stock, worth $4.14 Million. This represents 1.99% of its overall portfolio holdings.

Number of Shares
714,285
Previous 714,285 -0.0%
Holding current value
$4.14 Million
Previous $6.25 Million 42.52%
% of portfolio
1.99%
Previous 3.31%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022

BUY
$2.83 - $6.7 $2.02 Million - $4.79 Million
714,285 New
714,285 $2.12 Million

Others Institutions Holding TERN

About Terns Pharmaceuticals, Inc.


  • Ticker TERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,613,800
  • Market Cap $218M
  • Description
  • Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and obesity. The company develops TERN-101, a liver-distributed and non-bile acid farnesoid X receptor agonist, which is in Phase IIa clinical t...
More about TERN
Track This Portfolio

Track Decheng Capital Management Iii (Cayman), LLC Portfolio

Follow Decheng Capital Management Iii (Cayman), LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Decheng Capital Management Iii (Cayman), LLC, based on Form 13F filings with the SEC.

News

Stay updated on Decheng Capital Management Iii (Cayman), LLC with notifications on news.